http://www.nytimes.com/2016/09/15/arts/design/hudson-yards-own-social-climbing-stairway.html?ref=todayspaper

Buying the Stairway…to Hearing

By Amyn Amlani and Holly Hosford-Dunn There’s a lady who’s sure All that glitters is gold And she’s buying a stairway to…[hearing]. We’re recalling the lyrics to Led Zeppelin’s Stairway to Heaven, as an inspiration for our series of posts on pricing.  In Part 3 of our series of blogs on pricing that commenced in…

Read More

Where’d Those Numbers Come From? Data for the 2016 Pricing Series

“I think it’s inevitable that the upward trend line will start to normalize and get flatter. The current market forces in play are going to begin dropping that trend line closer to CPI…albeit not nearly as much as the average consumer would like it to be…” (Comment from Anonymous on the 2013 Price series) Inevitable…

Read More

Price Functions in the US Wholesale Hearing Aid Market, part 2

Real Price at retail isn’t rising in general and is actually falling for Premium products.  Something similar but even more dramatic is happening on the wholesale level. So concluded last week’s post and is the jumping off place today.   Average Wholesale Price Functions   Average wholesale Price of hearing aids increased faster than inflation1…

Read More

Price Functions in the US Wholesale Hearing Aid Market

This series now steps into the dark and murky realm of manufacturers’ wholesale pricing of product to see how the market has changed since 2013.  The caveats remain the same:   Big assumptions:  Categorical lines separating Economy, Premium, and everything in between are arbitrary to some extent, reflecting the varying family of products, product-specific technology levels,…

Read More
https://www.pinterest.com/zambianprincess/the-most-interesting-man-in-the-world-quotes/

Mucking Around with Hearing Aid Price, Again

by Holly Hosford-Dunn, PhD and Amyn Amlani,PhD   The Pricing series revs up for a multi-year update today, just in time to get in on the PCAST and IOM action of recent days and await signs from the FDA.  In 2013, the announced intent was to “dive down and muck around with Price to test…

Read More